Por: Politico Health August 22, 2023
Two generic drug giants agreed Monday to settle long-running criminal price-fixing charges with the Justice Department, including the unusual move to sell off the drugs involved. The U.S. arms of and are paying $225 million and $30 million, respectively, according to court filings. The companies agreed to enter into deferred prosecution agreements, a resolution in which charges are suspended but a company must admit wrongdoing. It can later face... + full article
ABC News USA Business August 22, 2023
WASHINGTON -- The generic drug maker Teva Pharmaceuticals agreed Monday to pay $225 million to settle price-fixing charges related to sales of a major cholesterol-lowering drug. The U.S. Department of Justice said the agreement also requires Teva to divest its business making... + más
Teva Pharmaceuticals to pay New York $523 million to settle claims from its role in opioids crisis | ABC News
How To Lower Your Cholesterol Naturally, According To Heart Experts | Forbes
NBC News USA Business July 16, 2023
When Akorn Pharmaceuticals shut its doors in February, hospitals across the country felt it. The Lake Forest, Illinois-based drugmaker was responsible for producing 75 generic drugs, all of which were pulled from the market when the company closed down. In some cases, the... + más
What Are the Duties of A Trustee? | Forbes
NBA playoffs 2023: Our insiders dissect the Eastern and Western conference finals | ABC7
New York Post USA Life June 27, 2023
A shortage of cancer drugs is forcing doctors to confront the reality that some patients could die needlessly. “Lives will be shortened,” Dr. Patrick Timmins III, a gynecologic oncologist at Women’s Cancer Care Associates in Albany, New York, . “A lot of people are going... + más
Where to eat in the dead of winter in R.I. | The Boston Globe
The Cancer-Drug Market Is a Disaster | The Atlantic
The Atlantic USA Opinion June 15, 2023
Brand-name drugmakers like to pay lower-cost rivals not to compete—and courts too often let them.Illustration by The Atlantic. Source: Getty.June 15, 2023, 7 AM ETAntiretroviral drugs are one of the pharmaceutical industry’s great achievements. They have turned HIV/AIDS from... + más
The DOJ's antitrust case against Google is ambitious but risky | CNBC
Teva to Slim Down Generic Drug Business in Turnaround Effort. The Stock Is Jumping. | MarketWatch
MarketWatch USA Business May 18, 2023
Teva’s ADR jumped 7.3% on Thursday morning, as investors awaited an investor day presentation scheduled to start at 12 p.m. Eastern. The drugmaker has been struggling since a series of ill-advised acquisitions a decade ago, notably the decision to buy Actavis Generics for... + más
Forbes USA Tech January 01, 2023
Mark Cuban's Cost Plus Drug Company is making waves. It is seen as a disruptor in generic drug ... [+] pricing. (Photo by Luka Dakskobler/SOPA Images/LightRocket via Getty Images)SOPA Images/LightRocket via Getty Images Mark Cuban's Cost Plus Drug Company (MCCPDC) is... + más
Why Mark Cuban Is Selling Anti-Fungal Ointment for $7.34 | Time
At Least 5 Dead After Boat Collides With Cuban Coast Guard Ship: Cuban Media | NBC 6 South Florida
Los Angeles Times USA Opinion September 24, 2022
Carvedilol could be the poster child for how to lower drug prices. Since 2007, over 20 million patients with cardiovascular conditions have enjoyed generic versions of the popular beta-blocker, which cost 2 cents a dose compared with $4.81 for the brand-name product. Patents on... + más
Here's what Medicare recipients should know about Inflation Reduction Act | 10 WBNS
FDA warns against 'very unsafe' social media trends targeted at teenagers | ABC News
About iurex | Privacy Policy | Disclaimer |